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Abstract 
Objective 
To quantify survival and neurodevelopmental outcome of fetuses with prenatally 
detected isolated severe bilateral ventriculomegaly form published literature. 
Methods 
Medline, Embase and the Cochrane Library were searched electronically. Only 
cases with prenatal diagnosis of apparently isolated severe ventriculomegaly 
and postnatal neurodevelopment assessment were selected and included. 
Severe ventriculomegaly was defined by the authors as enlargement of the 
ventricular atria, with a diameter greater than 15 mm on the transventricular 
plane while all cases where the investigators were unable to detect associated 
structural abnormality, chromosomal abnormality or fetal infections, and 
regarded the ventriculomegaly to be apparently isolated were included. Those 
where an etiology was identified prenatally were excluded, whereas those with 
post-natal identification of underlying cause were not excluded since this 
information was not available prenatally.  
The quality of the included studies was assessed using the Newcastle-Ottawa 
Scale (NOS) for cohort studies. Pregnancy outcomes, such as pregnancy 
termination, stillbirth, neonatal survival and developmental outcome of the baby 
were recorded. The degree of handicap was classified as no handicap, mild or 
severe handicap. Statistical assessment was performed by meta-analyses of 
proportions to combine data, weighing the studies by the inverse variance 
method and using a random-effects model. Proportions and confidence 
intervals were reported.  
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Results 
Eleven studies with 137 fetuses were found. Twenty-seven pregnancies 
underwent termination and were excluded. The remaining 110 fetuses with 
apparently isolated severe ventriculomegaly, where continuation of pregnancy 
was intended, forms the population included in the study. The overall quality 
assessed using the Newcastle-Ottawa Scale (NOS) for cohort studies was 
good.  
Survival was reported in 95/110 (pooled proportion 87.90%, 95% CI = 75.6% to 
96.2%) cases. In 15/110 (pooled proportion 12.1%, 95% CI = 3.8% to 24.4%) 
either stillbirth or neonatal demise was reported. No handicap was reported in 
41/95 of survivors (pooled proportion 42.2%, 95% CI = 27.5% to 57.6%). 
However, 17/95 showed mild-moderate handicap (pooled proportion 18.6%, 
95% CI = 7.2% to 33.8%) and 37/95 were reported to have had severe 
handicap (pooled proportion 39.6%, 95% CI = 30.0% to 50.0%).  
Conclusion 
Four fifths of fetuses with severe ventriculomegaly survive and of these, just 
over two fifths show normal neurodevelopment. The overall survivors without 
handicap account for more than one third of the total. Given that many cases 
undergo termination of pregnancy and the need for longer follow-up in order to 
detect subtle abnormalities, mortality and prevalence of developmental delay 
may be even higher than that reported in this paper. 
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Introduction 
Ventriculomegaly is one of the most frequently diagnosed fetal 
abnormalities of the fetal central nervous system 1. It is defined as enlargement 
of the ventricular atria greater than 10 mm, measured on the trans-ventricular 
plane, at the level of the glomus of the choroid plexus, perpendicularly to the 
ventricular cavity, positioning the calipers inside the echoes generated by the 
lateral walls2. Severe VM is usually defined as enlargement of the ventricular 
atria, with a diameter greater than 15 mm on the transventricular plane,  
compared to mild to moderate ventriculomegaly when the atrium measures 10 
to 15 mm 3. The prevalence of severe ventriculomegaly at birth is 0.3-1.5 per 
1000 pregnancies4,5. Prognosis is strongly dependent on the etiology, frequently 
challenging to identify antenatally, and is worse in cases with associated 
abnormalities6.  
There are many publications on isolated mild or moderate 
ventriculomegaly7. However, data on isolated severe ventriculomegaly is 
scarce. Most frequently the literature describe cases of severe ventriculomegaly 
associated to extra-cranial abnormalities, leading to poor outcome (livebirth rate 
30-40%4,8,9). The high mortality rate is partly due to the inclusion of terminations 
of pregnancy, cephalocentesis and cases that were not actively treated post-
natally  10. Conversely, pediatric surgical literature  reports high survival rates 
and low rates of neurodevelopmental handicap, with a 10-year survival rate 
after surgery of 60% or more, and normal intelligence in half of the surviving 
patients 11. In the study of Lumenta et al, normal development is reported in 
62.8% of children, while 29.8% had mild developmental delay, and only 7.4% 
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reported severe developmental delay12.  After surgery, the proportion of children 
with normal intelligence, measured by IQ, was reported between 50 and 63% 
with integration into normal school for 60% of the children13.  
In the series showing mainly poor prognosis14,15,4, additional 
abnormalities were seen in the majority of cases. The literature on the 
neurodevelopmental outcomes of isolated cases remains still quite sparse 16, 
negatively impacting parents’ counselling and remaining  for them a source of 
considerable anxiety 17,18.  
The aim of this study was to collate published data on survival and 
neurodevelopmental outcome of prenatally detected cases of apparently 
isolated severe ventriculomegaly.  
 
Methods 
Protocol, Eligibility Criteria, Information Sources and Search 
We performed a systematic review following the recommendations for 
systematic reviews and meta-analyses19,20. The search strategy was set up 
using a combination of relevant medical subject heading (MeSH) terms, 
keywords and word variants for “prenatal”, “diagnosis”, “ultrasound”, “severe 
ventriculomegaly” “neurodevelopment”. We searched Medline, Embase and the 
Cochrane Library including the Cochrane Database of Systematic Reviews 
(CDSR), Database of Abstracts of Reviews of Effects (DARE) and The 
Cochrane Central Register of Controlled Trials (CENTRAL) on the 11th of July 
and 24th of August 2017. No language restrictions were applied. We limited the 
search to the year 1990 or later, because the diagnostic techniques (high 
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resolution ultrasound, fetal Magnet Resonance Imaging (MRI), chromosomal 
micro-Array) were not widely available before then. No restrictions were applied 
in terms of study designs and size except for case series, observational studies 
or case reports of less than three cases, which were excluded to minimize 
publication bias. Additional relevant articles were identified by manual search in 
the reference lists of the included publications. The study was registered with 
PROSPERO database, 
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD420170487
12, (registration number CRD42017048712). 
Study Selection, Data Collection and Data Items 
Two independent reviewers (SC and A.K.) performed the literature 
search and identified the potentially relevant citations. The abstracts were 
screened independently, and relevant ones were selected for extraction of full 
text article. Relevant data were extracted, and potential inconsistencies were 
discussed by the authors and consensus was reached by weighing arguments. 
In instances where the data of interest were not explicitly reported by the 
authors of the papers, we contacted them for clarification or additional details. 
The studies assessment and selection for inclusion was performed 
accordingly to the following criteria: population, outcomes and study design. 
The inception cohort was assembled at the time of prenatal detection of 
ventriculomegaly, where the intention was to continue the pregnancy. Severe 
ventriculomegaly was defined as an atrial measurement in the trans-ventricular 
plane of 15 mm or above for the purpose of this review. As mentioned 
previously, ventriculomegaly was considered apparently isolated if the 
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investigators were unable to detect other cranial/extracranial structural 
abnormality, chromosomal abnormality or fetal infection in the prenatal period. 
We excluded all non-isolated cases where an etiology was identified prenatally, 
such as chromosomal abnormalities, spina bifida, structural brain defect 
detected on ultrasound or MRI (encephalocele, neuronal migration defect etc.) 
and congenital infections. We also excluded ventriculomegaly complicating 
monochorionic twin due to the high likelihood that this was a consequence of 
placental sharing. 
Studies where intrauterine treatments were systematically performed 
were excluded as it might have altered the natural history of the disease and 
being the techniques not standardized yet. Studies reporting only on unilateral 
ventriculomegaly were also excluded a priori. We included cases considered 
apparently isolated in the prenatal period. Cases with post-natal identification of 
underlying cause were not excluded since this information was not available 
prenatally. The pregnancy outcome (termination/stillbirth), neonatal survival and 
developmental outcome of the newborns were recorded. Cases were not 
eligible for inclusion if the ventriculomegaly was detected only post-natally.  
For the assessment of presence and degree of handicap, no limitations 
or restrictions were planned on the diagnostic tools and/or duration of post-natal 
follow-up. The degree of handicap was classified as no handicap, mild or 
severe handicap. We reported the results obtained by the tools for the 
assessment of neurodevelopment used by the primary authors, and seeking 
clarification from them when necessary. Handicap was classified as severe 
motor when independent functioning of the individual was not deemed possible. 
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Sensorineural handicap was considered severe where the developmental 
assessment tool reported it as such, or when attendance of mainstream school 
was not deemed possible. Children who did not fit into either severe handicap 
or no handicap were classified as mild/moderate. If information on the specific 
clinical finding rather than specific degree of handicap at the postnatal follow-up 
was available, the handicap class was assigned based on the reported 
information.    
 
Risk of Bias, Summary Measures and Synthesis of the Results 
The quality of the included studies was assessed using the Newcastle-Ottawa 
Scale (NOS) for cohort studies21. The NOS judges each study according to the 
following categories: selection of the study groups, comparability of the groups 
and ascertainment of the outcome of interest. The selection of the study groups 
is performed by evaluating the representativeness of the exposed cohort, the 
selection of the non-exposed cohort, ascertainment of exposure and the 
demonstration that the outcome of interest was not present at the start of the 
study. Comparability of the groups was assessed by evaluating of the cohorts 
based on the design or analysis. The ascertainment of the outcome of interest 
included the evaluation of the assessment of the outcome parameters, and the 
length and adequacy of the follow-up. A study can be awarded a maximum of 
one star for each item within the selection and outcome categories. Additionally, 
a maximum of two stars can be given for comparability21.  
Statistical assessment was performed by meta-analyses of proportions to 
combine data. The studies were weighted by the inverse variance method for 
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pooling. Forest plots were used to explore graphically in between-study 
heterogeneity, while heterogeneity was statistically evaluated using I2, which 
represents the percentage of between-study variation that is due to 
heterogeneity rather than to chance22. A I2 of 0% indicates absence of 
heterogeneity, while  values of or above 50% suggest considerable 
heterogeneity23.  
We used a random-effects model since it is more conservative, and the 
observed heterogeneity was >50%. Statistical analysis was carried out using 
StatsDirect 3.1.8 (StatsDirect Ltd, Altrincham UK, 2017).   We did not use either 
Funnel Plots or formal statistical tests to explore publication bias. A total of 11 
studies is not an adequate number for interpreting funnel plots. Moreover, 
funnel plots can be misleading for exploration of publication bias, particularly 
when the number of studies is relatively small24. 
 
Results 
Study Selection and Characteristics 
A total of 448 possible citations were identified with the initial databases 
electronic search. After review of titles and abstracts, 417 articles did meet the 
exclusion criteria and were excluded. For the 31 publications that potentially 
met the inclusion criteria, full text manuscripts were retrieved. Two additional 
studies were identified by manual search of the reference lists8,15. After the 
analysis of the full test manuscripts, 22 studies which did not fulfill the inclusion 
criteria were excluded. The remaining 11 articles were finally included in the 
systematic review8,15–17,25–31 (Figure 1).  
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The quality assessment of the included studies using the NOS is shown 
in the supplementary material (Table S1). The included studies have an overall 
good quality for selection of group and the ascertainment of the outcome of 
interest. Common reasons for scoring low on quality assessment were cases 
derived from high-risk populations and lack of description of the outcome of 
individual cases. Follow-up varied widely in the different studies, ranging from 
one month up to 18 years. Several different assessment tools for the 
assessment of the neonatal neurodevelopmental outcome were used, ranging 
from self-rating questionnaires to standardized tests. 
All the data from the included articles, published between 1999 and 
2017, were collected in a time spanning from 1990 to 2013. Almost all the 
studies reported on ventriculomegaly in general, and included fetuses with 
severe (atrial diameter 15 mm or more) ventriculomegaly. We extracted 
information about apparently isolated severe ventriculomegaly from them. The 
gestational age at the ultrasound assessment varied from 15 weeks to term. 
General characteristics of the included studies are shown in table 1. 
Different development assessment tools were used in each study and 
the age of developmental assessment ranged from less than one to 18 years 
(see table 2 for more details). The karyotype was assumed to be normal if it 
was not performed before or after birth, provided the phenotype after birth was 
normal. Data on infection screening, details of ventriculoperitoneal shunt 
placement and post-mortem investigation were collected when available.  
Four studies15,26–28 reported the outcomes in two degrees of delay 
(normal or significant abnormal, good or poor prognosis and normal or evident 
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psychomotor delay). We classified the ‘significant abnormal’, ‘poor prognosis’ 
and ‘evident psychomotor delay’ as severe handicap. In one report17,  the 
authors described the outcome with the actual clinical finding (hemiparesis, 
impaired visual attention) rather than with a classified degree of handicap. This 
was recorded as severe handicap after obtaining clarification from the authors. 
Pregnancy terminations were reported when available but excluded from the 
calculation of the survival rate.  
Synthesis of the Results 
Significant heterogeneity was found between included studies, being I2 
above 50% in almost all the outcomes analyzed, hence the decision for a 
random-effect model. Heterogeneity was low for severe handicap over 
survivors, but the 95% confidence interval was relatively wide (I2 = 4.2%, 95% 
CI: 0% to 53.2%).   
Meta-analysis of proportions was performed and Forest plots were used to 
describe the rates of death, survival and neurodevelopmental delay in severe 
isolate ventriculomegaly. Individual results for each one of the 11 studies 
included in the meta-analysis were provided in terms of proportions and 95% 
C.I., together with pooled results for all studies, where size of boxes was 
proportional to the study sample size.  
110 fetuses with prenatal apparently isolated severe ventriculomegaly were 
available. Of these, 95 survived and 15 had a stillbirth or neonatal demise. In 41 
of the survivors, the outcome was classified as normal, 17 were classified as 
mild/moderate handicap and 37 were reported as having severe handicap 
(Table 3).  
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The pooled proportion of deaths accounted for 12.1%, (15/100) (95% CI = 3.8% 
to 24.4%) while that of survival was 87.9% (95/110) (95% CI = 75.6% to 
96.2%), (Figure 2, Forest plot of deaths). 
No handicap was reported in 41/95 of survivors (pooled proportion 42.2%, 95% 
CI = 27.5% to 57.6%) (Figure 3, Forest plot of no handicap over survivors). 
However, 17/95 showed mild-moderate handicap (pooled proportion 18.6%, 
95% CI = 7.2% to 33.8%) (Figure S1, supplementary material, Forest plot of 
mild handicap over survivors) and 37/95 were reported to have had severe 
handicap (pooled proportion 39.6%, 95% CI = 30.0% to 50.0) (Figure 4, Forest 
plot of severe handicap over survivors).  
An overview of individual and pooled proportion of the different outcomes is 
available in tables 3 and 4.  
Additional anomalies were detected in nine cases (9.5%) only post-natally. The 
details of the additional anomalies are shown in Table S2. None of the infants 
with post-natally detected anomalies were free of handicap.  
   
Discussion 
Summary of Evidence  
We report on the outcome of children with prenatal detection of apparently 
isolated severe ventriculomegaly. Survival without handicap was seen in just 
over one third of cases. Although the initial diagnosis was isolated severe 
ventriculomegaly, additional structural abnormalities were detected post-natally 
in some. The degree of information available about the post-natal diagnosis of 
associated abnormalities was variable. Details on number of patients affected 
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and impact on outcomes as well as post-natal confirmation of the absence of 
associated abnormalities was available only from some reports (see table S2 of 
the supplementary material). Additional anomalies were detected in nine cases 
(9.5%) only post-natally, none of whom were without handicap.  
In cases of mild ventriculomegaly, the outcome is favorable in the absence of 
identifiable cause7. However, once the ventriculomegaly becomes severe, the 
outlook is unfavorable in the majority. The duration of follow-up was variable 
(Table 2) and may impact on the reported degree of handicap. Subtle 
abnormalities may not be uncovered until the child begins schooling. Therefore, 
the prevalence of developmental delay may be higher than that reported here.  
Pediatric surgical literature reports that developmental outcome following 
ventriculo-peritoneal shunt for obstructive hydrocephalus is normal in the large 
majority12,13. The presumed underlying cause in those patients is isolated 
obstruction to CSF flow in cases were the other investigations are normal. The 
results from prenatal literature do not match with those reported in post-natal 
series. The most likely reason for the disparity in the results is selection of 
children undergoing the surgical procedure. Obstruction to CSF flow 
(aqueductal stenosis) may be due to congenital or acquired reasons.  The 
results of this study suggest that the implications of the two are vastly different, 
and that the outlook for acquired aqueductal stenosis may be much more 
favorable as compared to that for congenital lesions. It could also be argued 
that children with severe ventriculomegaly that are asymptomatic after birth 
(hence with good prognosis) might never present for postnatal surgery. 
However, it is highly unlikely that fetuses with prenatal detection of severe 
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ventriculomegaly would not be followed up. On the other hand, pediatric 
surgeons do not see cases too compromised to undergo surgery in their series, 
in which case the selection bias would work against antenatally detected cases.  
Fetal MRI was not performed in every case. Many of the ones that did 
undergo MRI investigation were excluded from the analysis because of 
antenatal detection of associated abnormalities. We did not investigate those 
further, being this out of the scope of this paper.  Postnatally, additional 
abnormalities were found on MRI in four of the 17 cases (23.5%) of the mild and 
five of the 37 cases (13.5%) of severe developmental delay. It is difficult to say 
if all the abnormal findings would have been detected prenatally, had a fetal 
MRI been performed. Very often, parental wish against intervention is a 
deterrent for prenatal investigation. The structural abnormalities detected after 
birth are potentially detectable on MRI. Therefore, we would recommend a 
prenatal fetal MRI in cases of severe ventriculomegaly to ascertain the truly 
isolated cases. Similarly, not all parents chose to undergo an invasive test. 
Chromosomal micro-array is capable of detecting known pathogenic alterations 
in an additional 5% of cases even when conventional karyotype is normal32. 
This investigation has only recently become available in clinical practice and 
may not have been available for the series included in this review. Also, fetal 
MRI is able to diagnose additional brain abnormalities in 5% of cases33, but only 
in the last decade it has gradually been introduced as an additional fetal CNS 
investigation. Some of the ‘apparently’ isolated cases may no longer remain 
isolated, had they been subjected to chromosomal micro-array analysis, fetal 
MRI or appropriate neuro-sonography accordingly to the current standard 
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guidelines (ISUOG guidelines). However, these are the reports of leading 
centers throughout the world, and the results are a pragmatic representation of 
real-life situations.  
Limitations  
We conducted a thorough search of the literature in duplicate, according 
to a pre-specified inclusion and exclusion criteria. We excluded case report with 
fewer than three cases in order to avoid publication bias. Therefore, the results 
of the review are robust. Apparently isolated severe ventriculomegaly is not a 
common condition. A considerable proportion of pregnancies are terminated, 
thus modifying the natural history. Both these are responsible for the limited 
number of cases this report is based on. It is possible that cases undergoing 
termination might have been the ones with most severe ventriculomegaly.   
Table 2 displays the method used for assessment of neurodevelopment in the 
included studies. Some authors refers to Neuropediatric or Pediatricians’ 
assessment without additional details 15,26. Regardless of the method used to 
define degrees of neurodevelopmental delay, the focus of this systematic 
review was to identify cases with “normal” outcomes. The state of normality 
should be comparable between several studies, regardless of the method of 
neuro-developmental assessment.  
 
Implications for Clinical Practice and Future Perspectives 
The prevalence of developmental delay reported in this review may 
overestimate the real risk, given that not all the apparently isolated 
ventriculomegaly were truly isolated after birth, and some of them had 
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associated abnormalities. Due to parental choice, retrospective nature and 
availability of particular investigations, not all cases underwent a fetal MRI or 
tests to assess chromosomal imbalance.   
The association between additional abnormalities and worse outcomes is 
well known. It may be argued that developmental delay may be related to the 
presence of associated abnormalities rather than the ventriculomegaly itself. 
However, the prevalence of developmental delay remains high even if cases of 
associated abnormalities are excluded. There are no data to support the 
assertion that developmental delay may be less frequent in ‘truly isolated’ 
severe ventriculomegaly. The figures contained in this systematic review is the 
current best evidence on which to base parental counselling.  
 
Conclusion  
After excluding cases of pregnancy termination, approximately four out of five of 
all fetuses with antenatal diagnosis of apparently isolated ventriculomegaly 
survive. There is a high (Three out of five) chance of neurodevelopmental delay 
in this group. The overall probability of survival without handicap is 41/110 
(36.66% (CI = 0.23 to 0.52)). 
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Legends for illustrations 
Table 1- General characteristics of the 11 studies included in the systematic 
review. 
Table 2- Developmental assessment tools adopted in the 11 studies included in 
the systematic review. 
Table 3- Overview of meta-analysis of proportions for Deaths, Survivors, Total 
handicap and Normal outcome out of the total number of included cases. 
Table 4-  Overview of meta-analysis of proportions for Normal outcome, mild, 
severe and total handicap the total number of survivors. 
Figure 1- Flow-chart of studies selection.  
**Reasons for exclusion: In 2 studies all cases had associated abnormalities: in 
1 study all cases had mild to moderate VM, but none had severe VM; in 5 
studies the data collection started before 1990; in 1 study there were no 
antenatal information available; in 3 studies there was no postnatal follow 
information; in 7 studies, mild/moderate and severe VM were pooled together 
and was not possible to connect each one of the severe cases with the 
corresponding outcome; in 3 studies intrauterine treatments were systematically 
performed.  
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Table 1 
Author Data  collection Study Design 
GA diagnosis 
(ws) 
Definition of severe 
VM 
Definition of Isolated 
VM 
Time of  
follow-up 
Beke et al. 1999 1993-1996 retrospective cohort study 27-36 
ventricular atria width 
>15 mm on the 
transventricular USS 
plane 
No evidence of 
associated anomalies, 
aneuploidy, 
chromosomal 
abnormalities, structural 
malformations, negative 
TORCH screening. 
3 to 36 months 
Breeze et al. 
2007 2001-2005 
retrospective cohort 
study 16-36 
ventricular atria width 
>15 mm on the 
transventricular USS 
plane 
Normal Karyotype, 
TORCH screening, 
FMAIT screening 
(offered to all patients), 
detailed fetal USS for 
anomalies by fetal 
medicine sub-specialist, 
MRI (offered if potentially 
influent on parents’ 
decision-making 
process). 
4 to 24 months 
Gaglioti et al. 
2005 1990-2000 
retrospective cohort 
study 15-36 
ventricular atria width 
>15 mm on the 
transventricular USS 
plane 
Normal detailed USS 
evaluation of fetal 
anatomy, ECHO, 
Karyotype, TORCH 
(offered to all patients). 
2 to 144 months 
Gezer et al. 2015 2007-2009 retrospective cohort study 17-34 
ventricular atria width 
>15 mm on the 
transventricular USS 
and MRI plane 
No associated 
abnormalities on USS 
and MRI investigations, 
no evidence of 
chromosomal anomalies, 
confirmed after birth. 
up to 24 months 
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Gezer et al. 2016 2007-2009 prospective cohort study NR 
ventricular atria width 
>15 mm on the 
transventricular USS 
and MRI plane 
No evidence of 
chromosomal anomalies 
or congenital infections, 
normal first and second 
trimester screening. 
6 to 24 months 
Graham et al. 
2001 1994-1999 
retrospective cohort 
study 18-22 
ventricular atria width 
>15 mm on the 
transventricular USS 
plane 
Normal karyotype and 
detailed anomaly scan, 
negative infective 
screening (offered to all 
patients). 
1 to 36 Months 
Kennelly et al. 
2009 2000-2008 
retrospective cohort 
study 18-36 
ventricular atria width 
>15 mm on the 
transventricular USS 
plane 
Normal fetal anomaly 
USS performed by fetal 
medicine sub-specialist, 
ECHO, karyotype, 
TORCH screening, 
screening for alloimmune 
thrombocytopenia, fetal 
MRI (offered to all 
patients) 
10 to 72 months 
Letouzey et al. 
2017 1994-2011 
prospective cohort 
study 22-37 
ventricular atria width 
>15 mm on the 
transventricular USS 
plane 
Normal detailed USS, 
MRI, karyotype, infection 
screening (offered to all 
patients). 
3 to 216 months 
Nan Chu et al. 
2016 2004-2013 
retrospective cohort 
study 18-36 
ventricular atria width 
>15 mm on the 
transventricular USS 
plane 
Normal detailed USS, 
karyotype, TORCH 
screening (offered to all 
patients). 
16 to 108 months
Omer Bar-Yosef 
et al. 2017 2010-2013 
prospective cohort 
study NR 
ventricular atria width 
>15 mm on the 
transventricular USS 
plane 
Normal detailed USS, 
karyotype, TORCH 
screening (offered to all 
patients). 
18 to 36 months 
Weichert et al. 
2010 1993-2007 
prospective cohort 
study 12-38 
ventricular atria width 
>15 mm on the 
transventricular USS 
plane 
Normal detailed USS, MRI, 
CGH-Array, genetic 
counselling, infection 
screening (offered to all 
patients). 
1 to 151 months 
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Table 2 
A
u
t
h
o
r
/
 
y
e
a
r
 
Assessment tool Definition of normal Definition of mild/moderate handicap Definition of severe handicap 
Time 
of 
follow-
up 
B
e
k
e
,
 
1
9
9
9
 Brunet-Lezine (Hungarian 
adaptation) test in infants, from 3 
months to 36 months of age; 
Hungarian adaptation of Stanford-
Binet test (Budapest-Binet test). 
None of the following 
delayed somatic and 
psychomotor development, 
mild motor and sensory 
disorders, without mental 
retardation 
neurological, mental or sensory 
disturbances, which permanently 
impair their social integration and limit 
educational 
goals. Children with cerebral palsy, 
microcephaly, sensory-neuronal 
hearing loss, poor vision or mental 
retardation DQ < 70 
3 to 36 
months
B
r
e
e
z
e
,
 
2
0
0
7
 
Amiel-Tison Assessment 
Complex scoring 
system, see 
reference 
Complex scoring system, see 
reference 
Complex scoring system, see 
reference 
4 
months 
to 2 
years 
G
a
g
l
i
o
t
i
,
 
2
0
0
5
 
Structured questionnaire administered 
to the parents, investigating locomotor 
activities and co-ordination of 
movements; hearing and visual 
capacity; development and quality of 
speech and socialization skills; learning 
performance; evolution of diagnosed a 
  
Mild anomaly: moderate 
motor skill problems (with or 
without tone and reflex 
anomalies), squint, 
nystagmus, mild speech 
difficulty, moderate learning 
problems and ventricular-
peritoneal shunt with normal 
motor development 
severe neurodevelopmental outcome: 
cerebral palsy (with or without the 
need for orthopaedic help, urinary 
incontinence, daily enemas, etc.), 
epilepsy, bradyacusia with prothesis, 
mono/bilateral blindness and mental 
retardation. 
2 to 12 
years 
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G
e
z
e
r
,
 
2
0
1
5
 
neurophysiologic examinations by 
neonatologist (Denver 
Developmental Screening Test, 
audiometric test, weight, length and 
head 
circumference measurements, 
parents’ questionnaires) 
Infants with normal 
physical and 
neurologic 
development and no 
health issues 
associated with VM 
N/A 
Infants who died in the antenatal or 
postnatal period due to VM; 
underwent caesarean section upon 
the decision of the hospital’s 
perinatology council on the basis of 
known poor prognostic factors such as 
progressive VM, intrauterine growth 
retardation, chromosomal 
abnormalities 
up to 
24 
months
G
e
z
e
r
,
 
2
0
1
6
 
Denver Developmental Screening 
test, audiometric test, mental status, 
strength, deep tendon reflexes, 
posture, tone, parental 
questionnaire 
Normal 
neurodevelopment N/A   
6 to 24 
months
G
r
a
h
a
m
,
 
2
0
0
1
 CAT/CLAMS (for problem-solving 
abilities and visual–motor 
skills/language deficits) 
score > 80 minor neurological morbidity: score of 70–80  
Major neurological morbidity: score < 
70, evidence of cerebral palsy, or 
seizure disorder 
1 to 36 
Months
K
e
n
n
e
l
l
y
,
 
2
0
0
9
 
Parents interview using the 
International manual of classification of 
impairments, disabilities and handicaps 
questionnaire – WHO 1980 evaluating 
locomotor activity, coordination of 
hand and eye, hearing and sight, 
development and quality of speech, 
learn 
  
Mild anomaly: moderate 
motor skill problems (with or 
without tone and reflex 
anomalies), squint, 
nystagmus, mild speech 
difficulty, moderate learning 
problems and ventricular–
peritoneal shunt with normal 
motor development 
Severe neurodevelopmental: cerebral 
palsy (with or without the need for 
orthopaedic help, urinary 
incontinence), epilepsy, mono/bilateral 
blindness and significant 
developmental delay. 
10 
months 
to 6 
years 
L
e
t
o
u
z
e
y
,
 
2
0
1
7
 
Amiel-Tison scores, Denver Scale, 
Plalisano score, Wechsler 
Preschool and Primary Scale of 
Intelligence, Terman–Merrill scale, 
Wechsler Intelligence Scale for 
Children III or IV.  
No motor or cognitive 
impairment was 
detected during 
follow-up 
Minor motor disorders and/or 
cognitive disorders such as 
dyslexia, visuospatial 
attentional deficits or learning 
disabilities, and/or minor 
behavioural disorders 
requiring specific care.  
Cerebral palsy grade 2 or greater on 
the Palisano scale, severe mental 
delay (IQ below 70) 
3 
months 
18 
years 
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N
a
n
 
C
h
u
,
 
2
0
1
6
 
paediatricians’ assessment (growth, 
locomotor activities, coordination, 
hearing and visual function, speech 
and socialization capacities, 
neurodevelopmental anomalies, 
other abnormalities and subsequent 
treatments), telephone interview, no 
reference to spec 
  N/A 
Significant abnormity: structural 
malformations; poor locomotor, 
speech or socialization skills; 
abnormal hearing or visual function; 
and neurodevelopmental delay or 
other anomalies 
16 
months 
to 9 
years 
O
m
e
r
 
B
a
r
-
Y
o
s
e
f
,
 
2
0
1
7 Vineland Adaptive Behaviour Scales 
(VABS) Score above 85 N/A Score below 85 
18 to 
36 
months
W
e
i
c
h
e
r
t
,
 
2
0
1
0
 
Neuropediatric assessment, no 
reference to specific tools.   N/A 
Psychomotor delay if evidence of 
neuropsychological impairments 
(ranging from language delay to 
severe mental retardation) or motor 
disabilities (including cerebral palsy, 
hemi- and tetraparesis) on 
neuropediatric assessment. 
1 to 
151 
months
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Table 3 
Authors 
D
e
a
t
h
s
 
 
(
I
U
D
&
N
N
D
)
 
P
r
o
p
o
r
t
i
o
n
 
 
95% CI 
  
L
i
v
e
b
i
r
t
h
s
/
 
s
u
r
v
i
v
o
r
s
 
P
r
o
p
o
r
t
i
o
n
 
 
95% CI 
  T
o
t
 
 
H
a
n
d
i
c
a
p
 
P
r
o
p
o
r
t
i
o
n
 
 
95% CI 
  
N
o
r
m
a
l
 
P
r
o
p
o
r
t
i
o
n
 
 
95% CI 
  
T
o
t
 
N
.
 
o
f
 
 
W
o
m
a
n
 
T
O
P
 
Beke et Al. 1999 0 0.0% 0.00 0.60 4 100.0% 0.40 1.00 3 75.0% 0.19 0.99 1 25.0% 0.01 0.81 4 0
Graham et al. 2001 0 0.0% 0.00 0.34 9 100.0% 0.66 1.00 8 88.9% 0.52 1.00 1 11.1% 0.00 0.48 9 0
Gaglioti et al. 2005 3 27.3% 0.06 0.61 8 72.7% 0.39 0.94 3 27.3% 0.06 0.61 5 45.5% 0.17 0.77 11 13
Breeze et al. 2007 0 0.0% 0.00 0.71 3 100.0% 0.29 1.00 3 100.0% 0.29 1.00 0 0.0% 0.00 0.71 3 0
Kennelly et al. 2009 7 41.2% 0.18 0.67 10 58.8% 0.33 0.82 9 52.9% 0.28 0.77 1 5.9% 0.00 0.29 17 1
Weichert et al. 2010 0 0.0% 0.00 0.18 19 100.0% 0.82 1.00 13 68.4% 0.43 0.87 6 31.6% 0.13 0.57 19 7
Gezer et Al. 2015 2 33.3% 0.04 0.78 4 66.7% 0.22 0.96 1 16.7% 0.00 0.64 3 50.0% 0.12 0.88 6 1
Nan Chu et al. 2016 0 0.0% 0.00 0.37 8 100.0% 0.63 1.00 3 37.5% 0.09 0.76 5 62.5% 0.24 0.91 8 5
Gezer et al. 2016 3 27.3% 0.06 0.61 8 72.7% 0.39 0.94 3 27.3% 0.06 0.61 5 45.5% 0.17 0.77 11 NK
Omer Bar-Yosef et 
al. 2017 0 0.0% 0.00 0.98 1 100.0% 0.03 1.00 0 0.0% 0.00 0.98 1 100.0% 0.03 1.00 1 0
Letouzey et al. 2017 0 0.0% 0.00 0.16 21 100.0% 0.84 1.00 8 38.1% 0.18 0.62 13 61.9% 0.38 0.82 21 NK
Total 15 12.1% 0.04 0.24 95 87.9% 0.76 0.96 54 49.9% 0.36 0.64 41 36.7% 0.23 0.52 110 27
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Table 4 
Authors 
N
o
r
m
a
l
 
P
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r
t
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95% CI   
M
i
l
d
 
h
a
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a
p
 
 
P
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t
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n
 
 
95% CI   
S
e
v
e
r
e
 
h
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n
d
i
c
a
p
 
P
r
o
p
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r
t
i
o
n
 
 
95% CI   
T
o
t
a
l
 
H
a
n
d
i
c
a
p
 
P
r
o
p
o
r
t
i
o
n
 
 
95% CI   
T
o
t
.
 
S
u
r
v
i
v
o
r
s
 
Beke et 
Al. 1999 1 25.0% 0.01 0.81 2 50.0% 0.07 0.93 1 25.0% 0.01 0.81 3 75.0% 0.19 0.99 4
Graham 
et al. 
2001 
1 11.1% 0.00 0.48 5 55.6% 0.21 0.86 3 33.3% 0.07 0.70 8 88.9% 0.52 1.00 9
Gaglioti 
et al. 
2005 
5 62.5% 0.24 0.91 1 12.5% 0.00 0.53 2 25.0% 0.03 0.65 3 37.5% 0.09 0.76 8
Breeze 
et al. 
2007 
0 0.0% 0.00 0.71 2 66.7% 0.09 0.99 1 33.3% 0.01 0.91 3 100.0% 0.29 1.00 3
Kennelly 
et al. 
2009 
1 10.0% 0.00 0.45 4 40.0% 0.12 0.74 5 50.0% 0.19 0.81 9 90.0% 0.55 1.00 10
Weichert 
et al. 
2010 
6 31.6% 0.13 0.57 0 0.0% 0.00 0.18 13 68.4% 0.43 0.87 13 68.4% 0.43 0.87 19
Gezer et 
Al. 2015 3 75.0% 0.19 0.99 0 0.0% 0.00 0.60 1 25.0% 0.01 0.81 1 25.0% 0.01 0.81 4
Nan Chu 
et al. 
2016 
5 62.5% 0.24 0.91 0 0.0% 0.00 0.37 3 37.5% 0.09 0.76 3 37.5% 0.09 0.76 8
Gezer et 
al. 2016 5 62.5% 0.24 0.91 0 0.0% 0.00 0.37 3 37.5% 0.09 0.76 3 37.5% 0.09 0.76 8
Omer 
Bar- 1 100.0% 0.03 1.00 0 0.0% 0.00 0.98 0 0.0% 0.00 0.98 0 0.0% 0.00 0.98 1
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Yosef et 
al. 2017 
Letouze
y et al. 
2017 
13 61.9% 0.38 0.82 3 14.3% 0.03 0.36 5 23.8% 0.08 0.47 8 38.1% 0.18 0.62 21
 Total 41 42.2% 0.28 0.58 17 18.6% 0.07 0.34 37 39.6% 0.30 0.50 54 57.8% 0.42 0.72 95
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